Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CorVel ( (CRVL) ) just unveiled an announcement.
On August 7, 2025, CorVel Corporation held its 2025 Annual Meeting of Stockholders, where shareholders voted on three key proposals. The election of six directors to serve until the 2026 meeting was conducted, with varying levels of support for each candidate. Additionally, the appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified. Lastly, the 2025 Stock Incentive Plan was approved, indicating continued strategic focus on incentivizing performance and aligning interests with shareholders.
Spark’s Take on CRVL Stock
According to Spark, TipRanks’ AI Analyst, CRVL is a Neutral.
The overall stock score for CorVel is primarily driven by strong financial performance, indicating robust growth and stability. However, the technical analysis shows bearish trends, and the valuation suggests the stock is overvalued. These factors collectively moderate the overall attractiveness of the stock.
To see Spark’s full report on CRVL stock, click here.
More about CorVel
CorVel Corporation operates in the healthcare management industry, providing services such as workers’ compensation solutions, liability management, and medical bill review. The company focuses on delivering technology-driven solutions to improve healthcare outcomes and reduce costs for its clients.
Average Trading Volume: 151,070
Technical Sentiment Signal: Hold
Current Market Cap: $4.61B
For detailed information about CRVL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money